DESCRIPTION

Malaysia’s second largest banking group, with complete ASEAN footprint

  • 12-Month Target PriceRM8.20
  • Current PriceRM6.67
  • Expected Return+22.9%
  • Previous target priceRM8.20
  • MarketMain
  • SectorFinancials
  • Bursa Code1023
  • Bloomberg TickerCIMB MK
  • Shariah-compliantNo

SHARE PRICE CHART

Visual chart data unavailable in this format.

  • 52 Week Range (RM)6.20 – 8.50
  • 3-Month Average Vol (‘000)15,593.2

SHARE PRICE PERFORMANCE

1M 3M 12M
Absolute Returns -1.9 -2.6 -13.9
Relative Returns -2.5 -5.9 -14.3

KEY STOCK DATA

  • Market Capitalisation (RM m)71,732.1
  • No. of Shares (m)10,754

MAJOR SHAREHOLDERS

Shareholder %
Khazanah Nasional 21.5
EPF 15.8
Amanah Saham Nasional 9.9

NOII To Remain Strong

CIMB hosted an analyst call where the group provided updates on the upcoming 2QFY25 results, scheduled to be announced on 29th August 2025. Amid headwinds on the macro front, loans growth momentum for wholesale and business banking remains uncertain, while credit demand from the consumer and commercial banking is stable. Nevertheless, we think that CIMB’s 2QFY25 could be supported by strong non-interest income (NOII), due to better trading and FX performance. We believe CIMB’s current valuation is attractive, trading at -2SD of its 5-year average P/B with the recent weakness pricing in impact from OPR cut. We reiterate our Outperform call on CIMB, on attractive dividend yield >6%, and its Forward30 (F30) strategy that should drive NOII growth.

  • Loans growth. We understand that credit demand for business and wholesale banking was lacklustre in 2QFY25, as corporates continued to adopt a wait-and-see approach, given the ongoing global economic uncertainties. However, loans growth momentum from the consumer and commercial segments was stable, backed by the existing pipeline, resulting in drawdowns in 2QFY25. Given the intensive competition within the non-retail loans, loans growth is likely moderate, due to CIMB’s disciplined pricing strategy.
  • Non-interest income. The NOII growth momentum should continue in 2QFY25, underpinned by stronger FX and trading income given the ongoing market volatility. Looking ahead, we think that the NOII growth momentum will be driven by the group’s cross-selling efforts as highlighted in its F30 strategy.
  • OPR cut is likely have minimal impact on NIM. Management indicated that on an annualised basis, a 25bps OPR cut, will have a negative 1-2bps impact on group level NIM. This translates to a potential RM50m-60m impact to the group’s FY25 bottom-line. However, CIMB’s active liability management (lower campaign deposit rates in May) and the SRR cut in May should help to cushion the negative impact from the OPR cut. Singapore NIM should see an uptick on a QoQ basis, due to timing of CASA campaigns and deposit repricing. However, in the longer run the SORA rate movements should have a negative impact on Singapore’s NIM.
  • No immediate stress in asset quality. We gather that asset quality remains benign, with no spikes in delinquencies across all operating markets, while direct exposure to trade related exposure loans remains minimal (<3% of loans book). Recall that the group updated its FY25 credit cost guidance to 25-35bps from 30-40bps in 1QFY25, due stable asset quality outlook in Singapore and Indonesia and stronger recoveries.
  • Potential upside in dividends. Management did not discount the possibility of special dividends and share buybacks, should loans growth slows and sufficient accumulation in capital. However, this would also be dependent on capital availability and share price valuation. Note that management guided a dividend payout ratio of 55% in FY25.